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 We investigated the prevalence of hybrid blaCTX-M among isolates from different hosts. 
 Hybrid blaCTX-M of subgroup 1 and 9 genes were found in 14 (5.6%) isolates. 
 There were variations in prevalence by host sources. 
 Hybrid blaCTX-M genes were mainly harbored on IncI1 or IncI2 plasmids. 








This study investigated 248 extended-spectrum β-lactamase-producing Escherichia coli 
isolates from 2012-2013 for hybrid blaCTX-M genes. blaCTX-M genes were detected in 228 
isolates of which 14 isolates were hybrid blaCTX-M-positive (six blaCTX-M-123, six blaCTX-M-64 
and two blaCTX-M-132). The 14 hybrid blaCTX-M-carrying isolates (eight from chickens, two 
each from pigs and cattle, one each from dog and rodent) were genetically diverse. All but 
two hybrid blaCTX-M were carried on IncI1 (five blaCTX-M-123) and IncI2 (six blaCTX-M-64 and 
one blaCTX-M-132) plasmids. Our IncI1 and IncI2 plasmids had pHNAH4-1-like and 
pHN1122-1-like RFLP patterns, respectively. Genetic relatedness of the plasmids to 
pHNAH4-1 and pHN1122-1 were confirmed by complete sequencing of three plasmids, 
pCTXM123_C0996, pCTXM64_C0967 and pCTXM132_P0421. Plasmids closely related to 
pHNAH4-1 and pHN1122-1, and carrying different blaCTX-M alleles have been reported from 
multiple geographic areas in China previously. The findings highlighted the wide 







Gram-negative bacteria producing CTX-M type extended-spectrum β-lactamases 
(ESBLs) are a major public health threat worldwide and have been found to be highly 
prevalent in human and animals (Woerther et al., 2013; Ho et al., 2012a). CTX-M sequence 
variants can be divided into six clusters (CTX-M-1, -2, -8, -9, -25 and KLUC subgroups) 
with less than 90% identity between cluster and more than 95% identity within clusters 
(D'Andrea et al., 2013). Point mutation is the predominant mechanism from which new 
CTX-M alleles arise. However, it is recently recognized that CTX-M variants could also 
evolve by homologous recombination of two different CTX-M genes (He et al., 2013; 
Nagano et al., 2009).  
In 2009, a novel variant, CTX-M-64 was found in Shigella sonnei from a patient with 
diarrhea after a trip to China (Nagano et al., 2009). Sequence analysis of CTX-M-64 revealed 
that it is chimeric with CTX-M-15-like regions in the N- and C-terminal moieties and 
CTX-M-14-like region in the central portion (Nagano et al., 2009). Currently, four hybrids of 
CTX-M-14-like and CTX-M-15-like subgroup enzyme have been reported. CTX-M-64, 
CTX-M-123 and CTX-M-132 are hybrid enzymes with CTX-M-15-like regions in the N- and 
C-terminal moieties and CTX-M-14-like region in the central portion and have been 
identified in E. coli isolates originating from pets, food animals and retailed meat in China 
(He et al., 2013; Li et al., 2010; Sun et al., 2010). CTX-M-137, a hybrid with 
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CTX-M-14-like N terminus and CTX-M-15-like C terminus, was identified from southern 
China in an E. coli clinical isolate in a patient with urinary tract infection (Tian et al., 2014).  
Since these CTX-M variants are chimeric, widely used subgroup-specific PCR assays 
for detection of CTX-M genes may failed to identify their presence (Woodford et al., 2006; 
Saladin et al., 2002). Therefore, information on the prevalence and distribution of the CTX-M 
hybrids are limited. Hence, this study was conducted to investigate the prevalence and 
molecular epidemiology of the CTX-M hybrid enzymes in E. coli from human and animal 
sources. In China, plasmid-mediated fosfomycin resistance has been reported to be emerging 
among CTX-M-producing isolates from animals (Hou et al., 2012; Ho et al., 2013b). 
Therefore, we also investigated the plasmid-mediated fosfomycin resistance determinants 
among the isolates producing CTX-M hybrids 
   
2. Materials and methods. 
2.1 Bacterial strains and susceptibility testing 
A total of 340 nonduplicated, consecutive urinary E. coli isolates were collected from 
four clinical microbiology laboratories over a two week period, from May to June 2013 (Ho 
et al., 2015). The laboratories together served about a quarter of the Hong Kong populations 
in different geographic districts. The inclusion criteria were: (1) patient age 18 years or above, 
(2) mid-stream urine specimen, and (3) significant growth of ≥105 CFU/ml. Among the 340 
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urinary isolates, 78 isolates were ESBL-producing. All ESBL-producing isolates were 
included in this study. 
Animal isolates were obtained from an ongoning antimicorbial surveillance program 
during September 2012-August 2013 (Ho et al., 2011a; Ho et al., 2013b). For cattle and pigs, 
rectal swabs were obtained from fresh carcasses in a centralized slaughterhouse in Hong 
Kong. Samples from chicken were obtained while the animals were temporarily held for 
inspection before sale in wet markets in Hong Kong. All the cattle were imported from 
mainland China. Pigs and chickens included animals reared in local farms and those imported 
from mainland China. Samples from stray dogs, stray cats and rodents were collected by 
trained staff at the Governmental Animal Management Centres. The stray animals and wild 
rodents were captured from urban areas from all over Hong Kong. The animals were sampled 
in batches and each batch was obtained on a different date: chickens (20 animals per batch), 
cattle (10 animals per batch), pigs (2–7 animals per batch), stray cats (1–10 animals per 
batch), stray dogs (1–10 animals per batch) and urban rodents (2–23 animals per batch). 
Samples (approximately 0.1 g of feces) were seeded with Dacron swabs onto MacConkey 
agars supplemented with 2 µg/ml cefotaxime or 2 µg/ml ceftazidime, as previously described 
(Ho et al., 2011a). In brief, 534 ESBL-producing E. coli isolates were recovered from 1090 
animals including 241 cats (52 batches), 200 chickens (10 batches), 255 dogs (72 batches), 
100 cattle (10 batches), 112 pigs (32 batches), and 182 rodents (11 batches). A subset of 170 
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ESBL-producing isolates (40 from dogs, 14 from cats, six rodents, 38 from chickens, 56 from 
pigs and 16 from cattle) were chosen randomly according to sampling date and animal type 
for testing.  The six rodent isolates include five from Rattus norvegicus and one from R. 
rattus.  
In total, 248 ESBL-producing isolates including 78 isolates from patients and 170 
isolates from animals were investigated. The isolates were stored in Microbank (Pro-Lan 
Diagnostics) at -80 oC until testing. A disc diffusion method was used for susceptibility 
testing and the results were interpreted according to the Clinical and Laboratory Standrads 
Institute guidelines (CLSI, 2014). A double-disc synergy test was used for detection of 
ESBLs (Ho et al., 1998). This study was approved by the University of Hong Kong’s 
Committee on Animal Ethics (CULATR). 
 
2.2 Genotyping 
PCR assays were used to assign the E. coli isolates to phylogenetic groups A, B1, B2, C, 
D, E and F (Clermont et al., 2013). Multilocus sequence typing (MLST) was carried out and 
results were analysed using the University of Warwick scheme 
(http://mlst.warwick.ac.uk/mlst/). 
 
2.3 Detection of antibiotic resistance genes 
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PCR and sequencing were used to investigate the antibiotic resistance genes. Primers for 
the  CTX-M subgroups (consensus, blaCTX-M1G, blaCTX-M2G, blaCTX-M8G, blaCTX-M9G, and 
blaCTX-M25G) have been described previously (Ho et al., 2011b; Ho et al., 2012a). Two primer 
pairs were designed for the detection of hybrid blaCTX-M by monoplex PCR assays: 
CTXM-1F and CTXM9-506B for blaCTX-M-64/123/132-like hybrid genes, and CTXM9-F and 
CTXM1-600B for blaCTX-M-137-like hybrid genes (Supplementary file, Table S1). The CTX-M 
allele was determined by sequencing the full length of the blaCTX-M gene using different 
combination of primers (Ho et al., 2012a; Ho et al., 2012b). Previously described primers 
were used to investigate for the presence of the plasmid-mediated fosfomycin resistance 
genes (fosA, fosA3, fosA4 and fosC2) (Ho et al., 2013a). 
 
2.4 Plasmid studies.  
Transferability of hybrid blaCTX-M in all the PCR-positive isolates was investigated by 
filter mating using E coli J53 (azide-resistant) as the recipient (1:2 ratio). Transconjugants 
were selected on MacConkey agar containing 150 µg/ml sodium azide, 1 µg/ml cefotaxime 
(Sigma) (Ho et al., 2012b). The transfer frequencies were expressed as the number of 
transconjugants per donor cell (T/D) as previously described (Lo et al., 2014). Plasmids were 
sized by the S1 nuclease-PFGE method (Ho et al., 2005). The replicon types for the E. coli 
transconjugants with hybrid blaCTX-M-carrying plasmids were determined by an expanded 
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PCR-based replicon typing scheme which recognizes HI1, HI2, I1, I2, L/M, N, N2, FIA, FIB, 
FIC, FIIA, F, K, B/O, W, Y, P, A/C, A/C2, T, X1, X2, X3 and X4 replicons (Carattoli et al., 
2005; Lo et al., 2014). Identification of the plasmid replicons was confirmed by sequencing 
of the PCR products. In all isolates, plasmid location of the blaCTX-M and replicons were 
confirmed by hybridization using specific PCR products as probes (Ho et al., 2011a). The 
IncI1 and IncI2 plasmids carrying hybrid blaCTX-M in the transconjugants or transformants 
were further analyzed by restriction fragment length polymorphism (RFLP) (Ho et al., 
2011b). Purified plasmids were digested separately with ApaL1 and EcoRI (Takara, Dalian, 
China) in accordance with the manufacturer’s recommendation. Plasmid MLST (pMSLT) 
typing (http://pubmlst.org/plasmid/) was used to further characterized the IncI1 plasmids. 
 
2.5 Plasmid sequencing.  
One of each of the plasmids encoding blaCTX-M-64, blaCTX-M-123, and blaCTX-M-132 were 
chosen for complete plasmid sequencing. pCTXM64_C0967 and pCTXM132_P0421 were 
both IncI2 while pCTXM123_C0996 was IncI1 by PCR-based replicon typing. The three 
plasmids were chosen from the predominant plasmid incompatibility groups (IncI1 or IncI2) 
and RFLP profiles. Plasmid DNA was prepared as described previously from E. coli J53 
transconjugant carrying each as the only plasmid (Ho et al., 2011c). All of them were 
sequenced by Ion Torrent system (Life Technologies) at approximately 500 fold coverage 
10 
 
according to the manufacturer’s recommendation. The reads were assembled by the Velvet 
assembler (version 1.2.10). Gaps in the plasmids were closed by additional PCRs and Sanger 
sequencing. Fully assembled plasmid sequences were verified by RFLPs of the plasmids with 
ApaL1 and EcorI. The RFLP patterns were then compared with the in silico restriction 
analysis result. The plasmids were annotated using the RAST Server and each predicted open 
reading frame (ORF) was further blasted against the National Center for Biotechnology 
Information (NCBI) non-redundant protein database using BLASTX. The prototype plasmids 
for IncI1 (R64, GenBank accession AP005147) and IncI2 (R721, AP002527) were used as 
references in annotation. WebACT and Geneious Pro (version R7; Biomatter Limited, 
Auckland, New Zealand) softwares were used for bioinformatics analysis). The nucleotide 
sequences have been deposited in the GenBank: pCTXM64_C0967 (KP091735), 
pCTXM123_C0996 (KP198616), and pCTXM132_P0421 (KP198615).   
 
3. Results 
3.1 Prevalence of blaCTX-M subgroups and blaCTX-M hybrid 
PCR showed that 91.9% (228/248) of the ESBL-producing isolates were blaCTX-M 
positive (Table 1), among which 26.3%-50% and 16.7%-67.9% had blaCTX-M9G and blaCTX-M1G, 
respectively, depending on the host source. Ten (4.0%) isolates were PCR positive for both 
blaCTX-M9G and blaCTX-M1G, and 14 isolates (5.6%) were PCR positive for 
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blaCTX-M-64/123/132-like hybrid genes. All isolates were negative for blaCTX-M-137-like hybrid 
genes. None carried blaCTX-M2G, blaCTX-M8G and blaCTX-M25G. The prevalence of hybrid 
blaCTX-M was 8.2% among all animal isolates (Table 1), highest among isolates from chickens 
(21.1%), following by rodents (16.7%), cattle (12.5%), pigs (3.6%) and dogs (2.5%). No 
hybrid blaCTX-M was identified among isolates from cats and human.  
 
3.2 Characteristics of hybrid blaCTX-M carrying E. coli isolates and plasmids 
 The 14 isolates carrying hybrid blaCTX-M were further characterized. Phylogenetic group 
analysis revealed that five isolates belonged to group A, four isolates to group E, two to group 
F, two to B1 and one to group D (Table 2). MLST revealed that the clones of the hybrid 
blaCTX-M carrying E. coli isolates were diverse. Three isolates were ST1011 while the 
remaining ones were singletons. The alleles of the hybrid blaCTX-M included blaCTX-M-64 (six 
isolates), blaCTX-M-123 (six isolates) and blaCTX-M-132 (two isolates).  
In conjugation experiments, the plasmids harbouring hybrid blaCTX-M could be 
transferred in 11 of the 14 isolates at frequencies of 10-2 to 10-5 per donor cells to the recipient 
J53 strain. No transconjugants were obtained for the remaining three isolates despite repeated 
attempts. For the three isolates with no transconjugants, one (strain C0925A) had transfer of 
the plasmid to DH5alpha recipient by transformation. S1-PFGE showed that only a single 
plasmid was transferred in all the transconjugants (n=11) and transformant (n=1) (Table 2). 
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Five transconjugants carrying blaCTX-M-123 had co-transfer of resistance to fosfomycin. 
Plasmids carrying hybrid blaCTX-M were approximately 70-110 kb in size. The replicon types 
of the hybrid blaCTX-M plasmids were IncI2 (n=7), IncI1 (n=5) and nontypable (n=2). The 
plasmid locations of the replicon and blaCTX-M genes were confirmed by hybridization. All six 
IncI2 plasmids carrying blaCTX-M-64 were subjected to ApaL1 or Ecor1 digestion and identical 
or similar patterns were obtained. All five IncI1 plasmids carrying blaCTX-M-123 were of 
plasmid ST108 (allelic profile 2/13/5/1/2) and they had identical or similar patterns after 
ApaL1 or Ecor1 digestion (Table 2). 
 
3.3 Analysis of plasmid sequences 
Three plasmids from the transconjugants were completely sequenced, including 
pCTXM123_C0996 (IncI1, 108,435 bp, GC 50.7%, 130 putative ORFs), pCTXM64_C0967 
(IncI2, 62,194 bp, GC 42.1%, 86 putative ORFs), and pCTXM132_P0421 (IncI2, 63,124 bp, 
GC 42.1%, 89 putative ORFs). The plasmid backbone of pCTXM123_C0996 shares high 
sequence homology with plasmids within the IncI1 group (Figure 1), such as the reference 
R64 with genes encoding replication (repY and repZ), maintenance and stability (yefA, 
parA/B, impB/A/C, yfhA, pndA/C), conjugation (24 tra and 3 trb genes), shufflon region (rci 
gene) and type IV pilus formation (13 genes, pilI to pilU). Overall, pCTXM123_C0996 share 
96.9% coverage and 93.1% identity with another IncI1, blaCTX-M-123-carrying plasmid, 
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pHNAH4-1 (KJ125070, 108,658 bp) obtained from a chicken E. coli isolate in Anhui, China. 
The resistance genes in pCTXM123_C0996 were found within two variable regions with 
length of 9.2 kb and 5.8 kb. The 9.2 kb region was flanked by an IS6100 and an IS26 at 
the two ends, and includes genes encoding macrolide (mph2) and fosfomycin (fosA3) 
resistance. The 5.8 kb variable region (Figure 2), including the hybrid blaCTX-M-123 and a 2721 
bp sequence matching IncI2 backbone was flanked by direct repeat sequences of 6 bp 
(TTATAC). The spacer length between the right inverted repeat (IRR) of the ISEcp1 and 
blaCTX-M-123 is 45 bp. The orf477 downstream was followed by a 112-bp fragment of a DNA 
modification methylase from IncA/C backbone. The sequence and context of this 5811 bp 
putative transposition unit, except for carrying different blaCTX-M alleles completely matched 
a region in eight of the IncI2 plasmids showed in Figure 1. The finding suggested that ISEcp1 
may have mobilized a fragment of IncI2 backbone in addition to blaCTX-M-123 and inserted it 
in an IncI1 backbone at the AT-rich region between the ybeB and yedA genes (Figure 2). The 
length of the intergenic sequences between ybeB and yedA, interrupted by the 5811 bp 
ISEcp1-transposition unit was 471 bp which was 100% identical to the uninterrupted 
intergenic sequence in the Inc1I plasmid pIFM3801 (KF787110).  
The two IncI2 plasmids (pCTXM64_C0967 and pCTXM132_P0421) shared a high 
degree of homology to each other and to other completely sequenced IncI2 plasmids, such as 
the reference R721 (Figure 1). Blast search identified another six IncI2 plasmids carrying 
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blaCTX-M-15/55/64/132 that have almost identical arrays of ORFs and genes to our two IncI2 
plasmids. The sequence of pCTXM64_C0967 and pCTXM132_P0421 have the highest 
identities to pHNAH46-1 (KJ020576, 100% coverage, 96.7% identity) and pHNLDH19 
(KM207012, 100% coverage, 98.1% identity), respectively (Figure 1). The two IncI2 
plasmids contained the following functional regions, which were common to all IncI2 
plasmids: replication (repR and repA), maintenance and stability (yaeC, yafA, parA, topB), 
conjugation (nikABC genes, tra genes), shufflon region (rci gene) and type IV pilus 
formation (with 11 genes, pilV to pilL). In our two IncI2 plasmids, as were the other six 
plasmids, the hybrid blaCTX-M was the only resistance gene present. In the eight 
blaCTX-M-carrying IncI2 plasmids, the 3090 bp ISEcp1-blaCTX-M-orf477-IncA/C 
transposition unit, flanked by a 5 bp direct repeat (GAAAA) was inserted at an identical 
position between the yajA gene and orf16 (a hypothetical protein) (Figure 2). In this region, 
the immediate blaCTX-M genetic context was 100% identical in the eight plasmids but different 
blaCTX-M alleles were carried: blaCTX-M-15 (pHNY2), blaCTX-M-55 (pHN1122-1, p1081-CTX-M 
and pSTH21), blaCTX-M-64 (pHNAH46-1, pCTX-M64_C0967) or blaCTX-M-132 (pHNLDH19, 
pCTX-M132_P0421) (Figure 1 and 2). In all eight blaCTX-M-carrying IncI2 plasmids, the 
length of the intergenic sequences between yajA gene and orf16, interrupted by a 
ISEcp1-transposition unit is 86 bp which is 100% identical to the uninterrupted intergenic 
sequence in other Inc2 plasmids not carrying blaCTX-M, such as pBK15692 (KC845573) 
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(Figure 2).  
 
4. Discussion 
This study demonstrated the widespread occurrence of hybrid CTX-Ms among isolates 
from diverse host sources but with wide variations in terms of prevalence. Relatively high 
frequencies (12.5%-21.1%) were found among ESBL-producing isolates from chickens, 
rodents and cattle while the frequencies in pigs and dogs were low (2.5%-3.6%). No hybrid 
CTX-M was identified in isolates from cats and humans. Three different CTX-M variants 
which are hybrids of CTX-M-1 subgroup and CTX-M-9 subgroup were detected. It is notable 
that CTX-M-64, CTX-M-123 and CTX-M-132 described so far have been linked to sources 
in different parts of China. CTX-M-64 has previously been found in a patient after a trip to 
China and in several animal species (chicken, cats and dogs) from Sichuan and Guangdong 
provinces, China (Li et al., 2010; Nagano et al., 2009; Sun et al., 2010). CTX-M-123 has 
been detected in one isolate each from chicken and pig in Anhui and Guangdong provinces, 
respectively while CTX-M-132 has been detected in meat products in Beijing (He et al., 
2013). This study extended those observations and revealed their presence in cattle and wild 
rodents (R. norvegicus).  
Our findings showed that the great majority of hybrid blaCTX-M genes were carried on 
IncI1 and IncI2 plasmids. The possibility of horizontal plasmid transfer is supported by the 
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detection of highly similar blaCTX-M-123-carrying IncI1 plasmids and blaCTX-M-64-carrying IncI2 
plasmids in different E. coli strains. The finding that three of the six IncI2 plasmids carrying 
blaCTX-M-64 genes are from the same E. coli ST type (ST1011) and all from chickens (Table 2) 
raises the possibility there was clonal spread of the strains. The presence of the same E. coli 
ST type or the highly similar plasmids carrying hybrid blaCTX-M over different time periods 
suggested that the resistance determinants were already endemic in the animals. IncI1 
plasmids are common (10-20%) among E.. coli isolates from humans and animals (Lo et al., 
2014) and are noted for their possession of many resistance genes, especially those encoding 
the CTX-M type ESBLs (Carattoli, 2013). Here, we further showed that this plasmid type has 
captured the emerging fosfomycin resistance fosA3 gene, which often co-harbor with 
blaCTX-M-3/14/55/65 on IncFII plasmids (Ho et al., 2013b; Ho et al., 2013a). The success of IncI1 
plasmid has been attributed to its very efficient conjugation system (tra, trb and pil loci) 
(Carattoli, 2013). In addition, the type IV pilus encoded by the pil locus contributes to the 
virulence of Shiga-toxigenic E. coli by promoting epithelial cell adherence and adherence to 
abiotic surfaces (Garcia-Fernandez et al., 2008; Dudley et al., 2006). IncI2 plasmids have 
scaffold similar to IncI1 plasmids, including the tra and pil systems. Owning to the inability 
of the PBRT to identify IncI2 (Carattoli et al., 2005), information on the prevalence of this 
plasmid type is more limited. Our whole plasmids alignment revealed that IncI2 plasmids 
carrying hybrid blaCTX-M were highly similar to plasmids carrying blaCTX-M-15 in pets and food 
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animals (pHN1122-1 like), other blaCTX-M-55-carrying plasmids detected in patient with 
Shigella sonnei (p1081-CTX-M) and Salmonella enterica (pSTH21), and to a 
blaCTX-M-55-carrying plasmid (pHN1122-1) in different parts of China (Qu et al., 2014; Lv et 
al., 2013), suggesting rapid dissemination of this plasmid type.   
In blaCTX-M-carrying IncI2 plasmids, it is notable that ISEcp1-transposition units 
carrying four different CTX-M alleles were located in identical position between yajA gene 
and orf16. The intergenic sequence over here is A+T-rich (GC content 33.7%). Previous 
studies demonstrated that ISEcp1-mediated transposition targets different variable A+T-rich 
sequences, and not in a site-specific manner (Cattoir et al., 2008; Poirel et al., 2005). Besides 
the GAAAA insertion site, the 86 bp intergenic sequence between yajA gene and orf16 
contains six other previously reported ISEcp1 targeted A+T sequences (Figure 2). Thus, the 
finding suggests that homologous recombination of the hybrid blaCTX-M has possibly occurred 
after insertion of a blaCTX-M-15/55-like gene in that location, rather than vice versa. CTX-M-55 
differs from CTX-M-15 by a nucleotide substitution resulting in A77V and could represent 
allelic variations. In the three hybrids (CTX-M-64, CTX-M-123 and CTX-M-132), the amino 
acid at position 77 is the same as CTX-M-15 (A77). Presence of a fragment of IncI2 fragment 
in the 5811 bp transposition unit carrying blaCTX-M-123 in an IncI1 backbone further support 
the hypothesis that hybrid blaCTX-M-123 originated from an IncI2 plasmid. Additional in vitro 
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experiments involving IncI2 plasmids are required to prove the temporal sequences of the 
ISEcp1-transposition and homologous recombination events. 
In conclusion, this study revealed widespread occurrence of the newly described hybrid 
CTX-M enzymes among E. coli isolates from a wide range of animals. Two groups of IncI1 
and IncI2 plasmids harboring different hybrid CTX-M alleles were mainly involved in their 
dissemination. The high detection rates among isolates from food animals is concerning 
because rapid ongoing spread to clinical isolates in human is possible through the food chain 
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Table 1. Distribution of CTX-M subgroups among the ESBL-producing E. coli isolates 
Source No (%, by row) by CTX-M subgroup 
 M1 M9 M1+M9 Hybrid None Subtotal 
Animals       
dogs 17 (42.5) 19 (47.5) 1 (2.5) 1 (2.5) 2 (5.0) 40 (100) 
cats 7 (50.0) 5 (35.7) 1 (7.1) 0 (0) 1 (7.1) 14 (100) 
rodents 3 (50.0) 1 (16.7) 0 (0) 1 (16.7) 1 (16.7) 6 (100)a 
chickens 10 (26.3) 9 (23.7) 7 (18.4) 8 (21.1) 4 (10.5) 38 (100) 
pigs 22 (39.3) 21 (37.5) 0 (0) 2 (3.6) 11 (19.6) 56 (100) 
cattle 8 (50.0) 6 (37.5) 0 (0) 2 (12.5) 0 (0) 16 (100) 
Subtotal 67 (39.4) 61 (35.9) 9 (5.3) 14 (8.2) 19 (11.2) 170 (100) 
       
Human 23 (29.5) 53 (67.9) 1 (1.3) 0 (0) 1 (1.3) 78 (100) 
Total 90 (36.3) 114 (46.0) 10 (4.0) 14 (5.6)b 20 (8.1) 248 (100) 
aThe six rodent isolates include five from Rattus norvegicus and one from R. rattus. The 
isolate tested positive for hybrod CTX-M originated from a R. norvegicus 





Table 2. Characteristics of CTX-M hybrid-carrying E. coli isolates and plasmids 1 
CTX-M gene  
and origin 
Date Isolate Phylogenetic 
group 
MLST Size (kb) Replicon RFLP-ApaLI RFLP-EcoRI Resistance in  
Transconjugantc 
blaCTX-M-123,          
Chicken 2013.1 C0925A E ST1485 110 I1 C1  F ESBL, Fot  
Chicken 2013.2 C0964A D ST2732 110 I1 C2  F ESBL, Fot  
Chicken 2013.3 C0996Aa A ST10  110 I1 C3  F ESBL, Fot  
Pig 2013.5 P490A F ST457 110 I1 C3  F ESBL, Fot  
Dog 2012.9 NTD0033A B1 ST1196 110 I1 C3  F ESBL, Fot  
Cattle 2013.8 X0520Ab A ST48  - NT - - - 
blaCTX-M-64          
Chicken 2012.7 C0851A E ST1011 70 I2 A1  D1 ESBL 
Chicken 2012.9 C0906A E ST1011 70 I2 A1  D1 ESBL 
Chicken 2013.2 C0967Aa E ST1011 70 I2 A1  D1 ESBL 
Chicken 2013.3 C0992A B1 ST224 70 I2 A2  D2 ESBL 
Chicken 2013.7 C1055A A ST93  70 I2 A3  D1 ESBL 
Rodent 2013.8 R1015A F ST117 70 I2 A1  D1 ESBL 
blaCTX-M-132          
Pig 2012.9 P0421Ta A ST3103 70 I2 B  E ESBL 
Cattle 2013.1 X0422Ab A ST746 - NT - - - 
MLST, multilocus sequence typing; RFLP, restriction fragment length polymorphism; NT, nontypable; -, not done  2 
aThe blaCTX-M carrying plasmid in the three strains were completely sequenced. 3 
bNo transconjugant or transformant could be obtained after multiple attempts. 4 
cResistance phenotypes involving extended-spectrum β-lactamases (ESBL), amikacin (Amk), chloramphenicol (Chl), ciprofloxacin (Cip), fosfomycin (Fot), 5 
gentamicin (Gen), cotrimoxazole (Sxt) and tetracycline (Tet).        6 
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Figure 1. Comparative analysis of linear plasmid maps for (A) three IncI1 plasmids, and 7 
(B) nine IncI2 plasmids. R64 and R721 are used as the IncI1 and IncI2 references, 8 
respectively. Grey shading denotes shared regions of homology and the similarities for 9 
between plasmids comparison are given as % coverage/% nucleotide identity. ORFs are 10 
represented by boxes and colored according to predicted gene function. White boxes indicate 11 
the plasmid scaffold regions. Yellow boxes indicated genes associated with plasmid transfer, 12 
including the tra locus, trb locus and pil locus. The tra, trb and pil genes are indicated in 13 
capital letter inside the boxes. Blue boxes indicate the genes associated with plasmid stability 14 
and maintenance. Green boxes indicate the mobile elements. Red boxes indicate the 15 
resistance genes. Orange boxes indicated the shufflon regions including the rci genes. Pink 16 
boxes indicated the replication-associated genes. Pink circles indicate the replication origin of 17 
transfer (oriT). All genes in the plasmids are shown, but the genes and regions in the maps are 18 
not drawn exactly in proportion to the length of the sequences. GenBank accession and sizes 19 
of the plasmids were as follows: pHNAH4-1 (KJ125070, 108.7 kb), pCTXM123_C0996 20 
(KP198616, 108.4 kb), R64 (AP005147, 120.8 kb), p1081-CTXM (KJ460501, 62.2 kb), 21 
pHN1122-1 (JN797501, 62.2 kb), pSTH21 (LN623683, 62.1 kb), pHNAH46-1 (KJ020576, 22 
62.2 kb), pCTXM64_C0967 (KP091735, 62.2 kb), pHNLDH19 (KM207012, 62.2 kb), 23 









Figure 2. Schematic representation of insertion of transposition units harboring 29 
blaCTX-M in IncI1 and IncI2 plasmid scaffold. A putative 5811 bp transposition unit carrying 30 
blaCTX-M-123, 112 bp IncA/C and 2715 bp IncI2 remnant fragments was inserted in the 31 
intergenic space between ybeB and yedA in two IncI1 plasmid scaffolds and was flanked by 32 
two direct repeats (DR2, TTATAC). Another 3090 bp ISEcp1-transposition unit carrying 33 
blaCTX-M-55 (p1081-CTXM, pHN1122-1, pSTH21), blaCTX-M-64 (pHNAH46-1, 34 
pCTXM64_C0967), blaCTX-M-132 (pHNLDH19, pCTXM132_P0421) or blaCTX-M-15 (pHNY2) 35 
with a similar immediate genetic context was inserted in the intergenic space between yjaA 36 
and orf16 in eight IncI2 plasmid scaffolds, creating two direct repeats (DR1, GAAAA). The 37 
open reading frames (ORFs) and genes are indicated by arrows and colored as in Figure 1. 38 
Direct repeat sequences are indicated in red. GenBank accession numbers of the two 39 
additional plasmids not shown in Figure 1 are: pBK15692 (KC845573) and pIFM3803 40 
(KF787110). DR, direct repeat; IRL, left inverted repeat; IRR, right inverted repeat 41 
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